All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.


In silico Antidiabetic Screening of Borapetoside C, Cordifolioside A and Magnoflorine

Author(s): P. Khanal*, B. K. Mandar, B. M. Patil and K. K. Hullatti1
Department of Pharmacology and Toxicology, 1Department of Pharmacognosy, KLE College of Pharmacy, Belagavi-590 010, India

Correspondence Address:
Department of Pharmacology and Toxicology, KLE College of Pharmacy, Belagavi-590 010, India, E-mail: [email protected]

The current study was aimed to screen borapetoside C, cordifolioside A, and magnoflorine against targets that are involved in the pathogenesis of type 2 diabetes mellitus. All active compounds were retrieved from PubChem database and protein molecules were downloaded from Protein Data Bank. Each protein was prepared using Discovery studio, and the binding pocket was predicted using castP. Each ligand was docked against the target proteins using AutoDock Vina 4.0. Drug-likeness, toxicity, PK-PD and probable antidiabetic activity of each compound were also predicted. Among the three phytoconstituents, magnoflorine scored highest drug-likeness score and also predicted to be a potent antidiabetic molecule. Comparisons were made with sitagliptin and repaglinide two clinically approved antidiabetic drugs